These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5811633)

  • 21. Porphyria-inducing activity of a series of pyridine and dihydropyridine compounds. Investigation in a cell culture system.
    Roomi MW
    J Med Chem; 1975 May; 18(5):457-60. PubMed ID: 1151957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of diet and drugs on hepatic microsomal aminopyrine N-demethylase activity in vitro and susceptibility to carbon tetrachloride in sheep.
    Seawright AA; Steele DP; Mudie AW; Bishop R
    Res Vet Sci; 1972 May; 13(3):245-56. PubMed ID: 5043126
    [No Abstract]   [Full Text] [Related]  

  • 23. Ontogeny of the chicken cytochrome P-450 enzyme system. Expression and development of responsiveness to phenobarbital induction.
    Lorr NA; Bloom SE
    Biochem Pharmacol; 1987 Sep; 36(18):3059-67. PubMed ID: 3632724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemically induced porphyria: prevention by prior treatment with phenobarbital.
    Kaufman L; Swanson AL; Marver HS
    Science; 1970 Oct; 170(3955):320-2. PubMed ID: 5460517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of actinomycin D on post-phenobarbital activity of hepatic microsomal drug-metabolizing enzymes in the rat.
    Wilson JT; Fouts JR
    J Biol Chem; 1966 Oct; 241(20):4810-2. PubMed ID: 5926185
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of pyridine and some pyridine derivatives on spectral properties of reduced microsomes and on microsomal drug metabolizing activity.
    Jonen HG; Hüthwohl B; Kahl R; Kahl GF
    Biochem Pharmacol; 1974 Apr; 23(8):1319-29. PubMed ID: 4824776
    [No Abstract]   [Full Text] [Related]  

  • 27. Drugs and porphyria.
    De Matteis F
    S Afr Med J; 1971 Sep; ():126-33. PubMed ID: 5150265
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes: lipid requirement for drug demethylation.
    Lu AY; Strobel HW; Coon MJ
    Biochem Biophys Res Commun; 1969 Aug; 36(4):545-51. PubMed ID: 4390187
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug interactions in experimental hepatic porphyria: a model for the exacerbation by drugs of human variegate porphyria.
    De Matteis F
    Biochem J; 1972 Apr; 127(2):21P-22P. PubMed ID: 5076650
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental porphyria. I. The experimental porphyrias--a group of distinctive metabolic lesions.
    Sweeney GD; Janigan D; Mayman D; Lai H
    S Afr Med J; 1971 Sep; ():68-72. PubMed ID: 4113777
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental porphyria.
    Tschudy DP; Bonkowsky HL
    Fed Proc; 1972; 31(1):147-59. PubMed ID: 4109797
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced porphyrin biosynthesis. VII. Species, sex, and developmental differences in the generation of experimental porphyria.
    Creighton JM; Marks GS
    Can J Physiol Pharmacol; 1972 Jun; 50(6):485-9. PubMed ID: 4403068
    [No Abstract]   [Full Text] [Related]  

  • 33. A sensitive radiometric assay of aminopyrine N-demethylation.
    Poland AP; Nebert DW
    J Pharmacol Exp Ther; 1973 Jan; 184(1):269-77. PubMed ID: 4405549
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.
    Kappas A; Bradlow HL; Bickers DR; Alvares AP
    J Clin Invest; 1977 Jan; 59(1):159-64. PubMed ID: 830660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed function oxidation in perfused rat liver. The effect of aminopyrine on oxygen uptake.
    Thurman RG; Scholz R
    Eur J Biochem; 1969 Oct; 10(3):459-67. PubMed ID: 4390651
    [No Abstract]   [Full Text] [Related]  

  • 36. [Obtaining microsomes by coprecipitation with Ca2+ and demonstration of enzyme induction using phenobarbital].
    Albrecht R; Pélissier MA; Manchon P; Rospars JP
    C R Seances Soc Biol Fil; 1973; 167(11):1552-7. PubMed ID: 4154129
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of the inductive effects of phenobarbital, methaqualone, and methyprylon on hepatic mixed function oxidase enzymes in the rat.
    Reinke LA; O'Connor MF; Piepho RW; Stohs SJ
    Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):45-53. PubMed ID: 239443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of postnatal development on drug-induced hepatic porphyria and the synthesis of cytochrome P-450. A biochemical and morphological study.
    Song CS; Moses HL; Rosenthal AS; Gelb NA; Kappas A
    J Exp Med; 1971 Nov; 134(5):1349-71. PubMed ID: 5112207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of porphyrinogenic (porphyria-producing) agents on avian embryonic hepatic glutathione S-transferase activity.
    Yeung TC; Gidari AS
    Biochem Biophys Res Commun; 1981 May; 100(1):205-11. PubMed ID: 7259745
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental hepatic porphyria: studies with steroids of physiological origin in man.
    Kappas A; Granick S
    Ann N Y Acad Sci; 1968 Jul; 151(2):842-9. PubMed ID: 5263692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.